Cubist Systematic Strategies’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$15.2M Buy
97,000
+46,500
+92% +$7.18M 0.07% 377
2025
Q2
$8.48M Buy
50,500
+40,500
+405% +$6.01M 0.04% 695
2025
Q1
$1.38M Buy
10,000
+4,000
+67% +$510K 0.01% 1636
2024
Q4
$710K Sell
6,000
-5,900
-50% -$689K ﹤0.01% 2003
2024
Q3
$1.32M Sell
11,900
-8,700
-42% -$910K 0.01% 1668
2024
Q2
$2.03M Sell
20,600
-4,500
-18% -$459K 0.01% 1325
2024
Q1
$2.81M Buy
25,100
+17,000
+210% +$1.83M 0.02% 1379
2023
Q4
$816K Sell
8,100
-45,100
-85% -$4.47M 0.01% 2202
2023
Q3
$4.62M Buy
53,200
+17,400
+49% +$1.57M 0.03% 801
2023
Q2
$3.39M Sell
35,800
-5,900
-14% -$498K 0.02% 1087
2023
Q1
$3.15M Sell
41,700
-67,200
-62% -$5.07M 0.02% 1302
2022
Q4
$8.37M Sell
108,900
-58,500
-35% -$4.45M 0.05% 608
2022
Q3
$11.2M Buy
+167,400
New +$10.6M 0.06% 409

Other funds holding CAH

Cubist Systematic Strategies's CAH Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Cardinal Health (CAH) in Q3 2025, closing a stake of 214 shares — an estimated $33.1K sold.

Cubist Systematic Strategies first reported a position in CAH in Q2 2014 and held it in 42 quarters. The position peaked at $36.2M in Q4 2022. 1,222 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Cardinal Health position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 214 Cardinal Health shares in Q3 2025, an estimated $33.1K.
  • Cubist Systematic Strategies first reported a position in Cardinal Health in Q2 2014 and held it in 42 quarters.
  • Cubist Systematic Strategies's Cardinal Health position peaked at $36.2M in Q4 2022.
  • 1,222 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.